Just because a business does not make any money, does not mean that the stock will go down. For example, although Amazon.com made losses for many years after listing, if you had bought and held the ...

Good morning, everyone, and welcome to the Atossa Therapeutics fourth quarter and full year 2024 earnings conference call. My name is Joelle, and I will be your conference operator today. (Operator ...

Metastatic breast cancer remains an area of critical unmet need, where improved therapies are urgently required,” said Steven Quay, M.D., ...

1. Patients randomised 1:1 in AIPAC-003 Phase II to receive 30mg or 90mg dosing of eft in combination with paclitaxel to ...

Today, several major companies are expected to report earnings: Canadian Solar (CSIQ), Cormedix (CRMD), GameStop (GME), ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) will likely be posting its quarterly earnings results on Tuesday, March ...

All listeners should provide the operator with the conference call name "Atossa Therapeutics Business Update" to join. Following the conclusion of the conference call, a replay will be available for ...

This surge reflects the increasing reliance on genetic diagnostics for identifying hereditary diseases, guiding cancer ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a report released on Wednesday,Benzinga reports. They currently have a ...

SEATTLE - Atossa Therapeutics, Inc. (NASDAQ:ATOS), a clinical-stage biopharmaceutical company with a market capitalization of $93 million, announced today its strategic decision to focus on metastatic ...